Free Trial

Cipher Pharmaceuticals Q1 2023 Earnings Report

Cipher Pharmaceuticals logo
C$11.53 -0.20 (-1.71%)
As of 04:00 PM Eastern

Cipher Pharmaceuticals EPS Results

Actual EPS
C$0.14
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cipher Pharmaceuticals Revenue Results

Actual Revenue
$6.61 million
Expected Revenue
$7.83 million
Beat/Miss
Missed by -$1.22 million
YoY Revenue Growth
N/A

Cipher Pharmaceuticals Announcement Details

Quarter
Q1 2023
Time
N/A

Conference Call Resources

Cipher Pharmaceuticals Earnings Headlines

Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.
See More Cipher Pharmaceuticals Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cipher Pharmaceuticals? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cipher Pharmaceuticals and other key companies, straight to your email.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals (TSE:CPH) Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, and Out-Licensed Products among others. The company's geographical segments include Canada and the United States.

View Cipher Pharmaceuticals Profile

More Earnings Resources from MarketBeat